Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIAT
Ratios

Coherus Oncology (CHRS) Long-Term Debt Repayments (2022)

Historic Long-Term Debt Repayments for Coherus Oncology (CHRS) over the last 1 years, with Q1 2022 value amounting to $109.0 million.

  • Coherus Oncology's Long-Term Debt Repayments changed N/A to $109.0 million in Q1 2022 from the same period last year, while for Dec 2022 it was $109.0 million, marking a year-over-year change of. This contributed to the annual value of $260.4 million for FY2024, which is N/A changed from last year.
  • Coherus Oncology's Long-Term Debt Repayments amounted to $109.0 million in Q1 2022.
  • Coherus Oncology's 5-year Long-Term Debt Repayments high stood at $109.0 million for Q1 2022, and its period low was $109.0 million during Q1 2022.